:quality(75)/dvgnzpfv30f28.cloudfront.net/10-13-2020/t_a853909a02684b2eb6079de99a41edab_name_Copia_de_PORTADAS_ARC_TRVSL.png)
Johnson & Johnson interrumpe ensayo de posible vacuna contra la COVID-19 por voluntario enfermo
El estudio buscaba inscribir hasta 60.000 voluntarios en alrededor de 215 lugares de investigación clínica.
- 13 de octubre de 2020 05:28 p.m.
- Duración: 02:01
:quality(75)/cdn.jwplayer.com/v2/media/i1HAjbHq/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/iotv0R2A/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/YaDdvsaa/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/71elp4EW/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/v2XbYuSU/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/7rxXj0Yw/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/GPfI9gWn/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/jLTo5yKQ/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/Fl5o0bUv/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/DJFQd0EL/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/iCpJ7XHa/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/9CsmKsQ6/poster.jpg)